Galderma Group AG (SWX:GALD)
Switzerland · Delayed Price · Currency is CHF 158.65
-4.20 (-2.58%)
Sep 4, 2026, 5:31 PM CET
Galderma Group AG Market Cap
Galderma Group AG has a market cap or net worth of 37 billion as of September 4, 2026. Its market cap has increased by 12.19% in one year.
Market Cap
37.00B
Enterprise Value
38.51B
Revenue
4.79B
Ranking
n/a
PE Ratio
53.76
Stock Price
158.65
ChartMarket Cap Chart
Since March 22, 2024, Galderma Group AG's market cap has increased from 15.20B to 37.00B, an increase of 143.32%. That is a compound annual growth rate of 43.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 37.00B | -3.87% |
| Dec 30, 2025 | 38.48B | 60.96% |
| Dec 30, 2024 | 23.91B | 57.25% |
| Mar 22, 2024 | 15.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 277.91B |
| Novartis AG | 248.92B |
| Lonza Group AG | 40.36B |
| Sandoz Group AG | 29.80B |
| Alcon | 28.18B |
| Straumann Holding AG | 15.53B |
| Sonova Holding AG | 13.90B |
| Bachem Holding AG | 5.62B |